Oct 15, 2026, 6:25 PMStock Market News
AbbVie, Eli Lilly and Gilead Stocks Near Record Highs
AbbVie, Eli Lilly and Gilead Sciences trade at or near record highs as a technology selloff steers investors toward perceived safety in big pharma stocks.
Listen to this briefingAudio briefing
Summary
MarketWatch reported on October 15, 2026, that AbbVie, Eli Lilly and Gilead Sciences shares were trading at or near record highs. The headline linked big pharma’s strength to investors seeking safer holdings during a technology stock selloff.
Only a short feed summary was available. It disclosed no share prices, percentage moves, record dates, valuation measures, company catalysts or financial results, leaving the scale and durability of the gains unquantified.
Positives
- AbbVie shares were trading at or near a record high, according to the October 15 report.
- Eli Lilly shares were trading at or near a record high, according to the available summary.
- Gilead Sciences shares were trading at or near a record high, according to the available summary.
- Investor movement toward perceived safety in big pharma accompanied the technology selloff, according to the headline.
Risks & concerns
- The available summary omitted share prices and percentage moves, so the magnitude of each stock’s rise was not disclosed.
- MarketWatch provided no company catalysts or financial results in the extract, limiting assessment of what supported the highs.
- The extract gave no valuation measures or record dates, leaving the stocks’ pricing and historical context unspecified.
Primary sourceMarketWatch.com - Top Storieshttps://www.marketwatch.com/story/big-pharma-stocks-near-all-time-highs-as-tech-selloff-pushes-investors-toward-safer-bets-0a5d5d07?mod=mw_rss_topstories
Read full article
